Health & Fitness
Wed, November 26, 2008Tue, November 25, 2008
Mon, November 24, 2008
Thu, November 20, 2008
Wed, November 19, 2008
Tue, November 18, 2008Alkermes Corporate Presentation to be Webcast at the NASDAQ Investor Program
//health-fitness.news-articles.net/content/2008/ .. o-be-webcast-at-the-nasdaq-investor-program.html
Published in Health and Fitness on Monday, November 24th 2008 at 14:25 GMT by Market Wire🞛 This publication is a summary or evaluation of another publication
CAMBRIDGE, Mass.--([ BUSINESS WIRE ])--Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by NASDAQ International on Thursday, December 4, 2008 at 1:45 p.m. GMT (8:45 a.m. EST). The presentation will be webcast from the Renaissance Chancery Court Hotel in London and may be accessed under the investor relations tab at [ www.alkermes.com ]. The presentation will be archived for 14 days.
Alkermes, Inc., a biotechnology company committed to developing innovative medicines to improve patients' lives, manufactures RISPERDAL® CONSTA® for schizophrenia and developed and manufactures VIVITROL® for alcohol dependence. Alkermes' robust pipeline includes extended-release injectable, pulmonary and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, Alkermes has research and manufacturing facilities in Massachusetts and Ohio.